Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: john.d who wrote (388)	2/6/2000 7:54:00 AM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

CORRECTION - February 7th - CNBC Interview With Ed Gallup, Immucor Pres/CEO, @ 12:00 Noon John, The CNBC Immucor interview is actually scheduled for February 7th @ 12:00 Noon. Sorry for the error! cnbc.com Best O'Luck! Tom

To: john.d who wrote (388)	2/9/2000 3:49:00 PM
From: Thomas Kirwin	Respond to of 422

The Story was Delayed! Yahoo! Immucor Message Board Re-post............. CNBC...great NEWS!!!!!!! by: technetx 2/9/00 11:44 am Msg: 4033 of 4040 OK, here's the scoop from RELIABLE sources: CNBC postponed Ed Gallup's interview because there is a better spot for him. CNBC wants to air the Immucor interview in conjunction with Pres. Clinton's speech about the medical errors problem. Immucor will be the focus for the remedy for the nation's blood typing hazards. The implication is that an investment opportunity exists because of Immucor's EXCLUSIVE position to save lives. This is MUCH bigger than a simple, isolated interview. It comes with built-in publicity on a national level. AS I have said, it is the Congress that we should be watching and the legislation that may be proposed. Remember, IMMUCOR is the ONLY company with techology in the field that can SAVE LIVES ....NOW! (ABS2000 and I-TRAC , specifically). WHEN: the interview will air right after Clinton gives his speech. I don't know when that speech will occur. I THINK , maybe the end of this week or the beginning of next week. AND, as I have posted before, the large volume of trades is NOT mostly because of the CNBC interview...there is more to it than that. Immucor will get the attention it deserves. DATELINE story is still alive and well... Nothing definite on this yet. Dominic